Cleo Diagnostics Ltd

Company Profile

Sector

Healthcare

Industry

Medical Devices

Employees

N/A

Website

www.cleodx.com

Country

Australia

Exchange

ASX

Cleo Diagnostics Ltd, a biotechnology company focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral.

It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.

Key Stats

52-Week Range

A$0.31A$0.90

Beta0.41

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.03

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.